Protara Therapeutics Reports Results for Quarter Ended June 30, 2026

What Happened
Protara Therapeutics, Inc. (TARA) filed a Form 8-K on August 11, 2026 (Item 2.02) announcing its financial results for the quarter ended June 30, 2026. The company disclosed the results in a press release that is attached to the 8-K as Exhibit 99.1. The filing also includes the cover page interactive XBRL file (Item 9.01).

Key Details

• Filing date: August 11, 2026 (Form 8-K).
• Period reported: Quarter ended June 30, 2026.
• Disclosure format: Results announced via press release attached as Exhibit 99.1.
• Technical exhibit: Cover Page Interactive Data File (Inline XBRL) is included.

Why It Matters
This 8-K signals that Protara has released its latest quarterly financial performance—important information for investors assessing the company’s near-term results and operational progress. Investors should read the attached press release (Exhibit 99.1) for the reported revenue, net income (or loss), cash position, and management commentary, and monitor the company’s upcoming periodic filings (e.g., Form 10-Q) for the full financial statements and additional detail. No other material events (e.g., executive changes or mergers) were reported in this filing.